Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature

In recent years, a growing number of reports in the literature have linked osteonecrosis of the jaw bones with intravenously administered bisphosphonates prescribed for the treatment of hypercalcemia of malignancy due to bone lesions of multiple myeloma or bone metastases in patients with breast or prostate cancer. Furthermore, an association between chronic oral bisphosphonate use in patients with osteoporosis or Paget's disease, and bone necrosis in the mandible or maxilla has been demonstrated in numerous case reports and case series in the last couple of years. Therapeutically, osteonecrosis of the jaws seems to be difficult to treat surgically, often resulting in a recurring or even progressing lesion. In the present case report of a bisphosphonate-associated osteonecrosis of the maxilla in a patient with osteoporosis, the current literature will be discussed, and open research questions and potential problems for our daily dental practice routine will be addressed.

Bouddhisme et éthique: le cas de l'euthanasie

Cet article vise à présenter les principales pistes d’analyse éthique qui ont été proposées en matière d’euthanasie dans la tradition bouddhiste. Les nombreuses branches et cultures issues et influencées par le bouddhisme engendrent une importante hétérogénéité de vues face à de telles questions. Une interprétation prudente de leurs valeurs et enseignements fondamentaux permet, cependant, de discuter la vraisemblance des théories exprimées par la poignée d’auteurs s’étant penchés sur la question. Certains discutent de l’action homicide du professionnel de la santé, se demandant, en particulier, si l’incontesté principe du respect de la vie ne pourrait être relativisé par une compassion à l’égard du patient à l’agonie. D’autres raisonnent dans une perspective de refus de traitement de la part d’un malade, situant donc exclusivement l’enjeu du côté du patient. L’article conclut que l’euthanasie ne serait pas acceptée par le bouddhisme, la question de la cessation des soins ou du refus de traitement étant plus difficile à trancher. Notre revue de littérature n’a pas identifié d’écrits provenant des principaux pays concernés par les mouvements bouddhistes. Il est ainsi difficile d’apprécier la place réelle de l’euthanasie dans le questionnement des théoriciens et professionnels de la santé dont la culture est empreinte de cette tradition.

[Collagenase injection in Dupuytren's disease, evaluation of the ultrasound assisted technique].

Since October 2011, the enzymatic lysis of Dupuytren's cord was introduced in Switzerland (Xiapex(®), Auxilium Pharmaceuticals, Pfizer). Here we present our first university experience and underline the major role of ultrasound during the injection. Between December 2011 and February 2013, 52 injections were performed to eliminate 43 Dupuytren's cords in 33 patients. The mean age of the patients was 64.4 ± 8.5 years. Complications were documented for each patient. Before, directly after and after a minimum of 6 months post-injection, the contracture of the treated joint was measured with use of a goniometer. The DASH score was evaluated after a minimum of 6 months and the patients were asked to subjectively evaluate the outcome of the treatment (very good, good, mild, poor) and whether they would reiterate it if necessary. Four skin defects, one lymphangitis, and one CRPS were responsible for a complication rate of 18%. There was no infection and no tendon rupture in the series. The mean MCP joint contracture was respectively 36.8 ± 27.4°, 3.5 ± 7.8° (gain of mobility compared to the preoperative situation 33.3°, P<0.001), and 8.4 ± 13.9° (gain 28.4°, P<0.001) respectively before, just after and at the long-term clinical control. The mean PIP joint contracture was respectively 36.5 ± 29.1°, 5.9 ± 6.7° (gain 30.6°, P<0.001), and 15.1 ± 13.8° (gain 21.4°, P<0.001) respectively before injection, just after and at the long-term clinical control. The DASH score decreased from 24 ± 14 to 7 ± 9 (P<0.001). Eighty-one per cent of the patients were satisfied or very satisfied of the treatment. All but two would reiterate the treatment if necessary. Ultrasound is able to target the injection of collagenase in order to reduce complications. The short-term results of this non-invasive therapy are very promising however comparison with conventional procedures is difficult as the long-term results are lacking.